WASHINGTON — Most executives at pharmaceutical companies haven’t directly donated to political candidates over the final stretch of the 2024 campaign. But those who have largely gave to Democrats.
A STAT review of contributions by CEOs of member companies and board members of the brand drug lobby PhRMA showed most executives just gave to their companies’ political action committees, if they gave at all.
But of the six executives who donated to individual candidates between July 1 and Sept. 30, five gave to Democratic candidates, even though Democratic lawmakers passed the most aggressive drug pricing reform in decades in 2022.
This article is exclusive to STAT+ subscribers
Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.
Already have an account? Log in
